What does remission mean for CLL and how is it monitored
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Understanding Remission in CLL and How It's Monitored
What Remission Means for CLL
Remission in chronic lymphocytic leukemia (CLL) means that your cancer is responding to treatment—the leukemia cells are decreasing significantly or becoming undetectable. However, it's important to understand that remission in CLL is somewhat different from a "cure."
There are two main types of remission:
-
Complete Remission (CR) - This is when tests can no longer detect CLL cells in your blood, bone marrow, or lymph nodes. The disease appears to be gone, though microscopic disease may still exist.
-
Partial Remission (PR) - This means the number of leukemia cells has decreased significantly (usually by at least 50%), but some disease is still detectable on testing.
Both are considered good responses to treatment, though complete remission is generally the preferred goal.
How Remission Is Monitored
According to the NCCN Guidelines for CLL, doctors use several methods to assess whether you're in remission and to monitor your disease over time:
Blood Tests
- Complete blood count (CBC) - Measures your white blood cells, red blood cells, and platelets
- Lymphocyte count - Tracks the number of CLL cells in your blood
- LDH (lactate dehydrogenase) - An enzyme that can indicate disease activity; elevated levels may suggest progression
Flow Cytometry
This is a specialized blood test that identifies and counts specific types of cells. It's particularly useful for CLL because it can detect the characteristic CLL cells even when they're present in very small numbers. Flow cytometry is considered the standard method for confirming CLL diagnosis and monitoring response to treatment.
Imaging Studies
- CT scans - Used to measure lymph node size and assess organs like the spleen and liver
- PET/CT scans - Particularly important if your doctor suspects disease progression or complications like Richter transformation (a serious change in the cancer type)
Physical Examination
Your doctor will regularly check for enlarged lymph nodes, spleen, or liver during office visits.
Important Context: CLL and Long-Term Monitoring
One key thing to understand about CLL is that even when you achieve remission, your doctor will continue monitoring you regularly—sometimes for years. This is because:
- CLL can remain stable for extended periods
- Some patients may eventually experience disease progression (called "relapse" or "recurrence")
- Early detection of any changes allows for timely treatment adjustments
According to the NCCN Guidelines, your oncology team will determine the appropriate monitoring schedule based on your specific situation, including the type of treatment you received and your individual risk factors.
Questions to Ask Your Healthcare Team
- What type of remission am I in (complete or partial), and what does that mean for my specific situation?
- How often will I need follow-up appointments and testing to monitor my remission?
- What specific tests will you use to monitor my disease, and how will you explain the results to me?
- What signs or symptoms should I watch for that might indicate disease progression?
- If my disease progresses, what treatment options would be available?
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Source Guidelines
NCCN Guidelines for Patients: Chronic Lymphocytic Leukemia (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with prognosis for CLL patients
Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: